Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Herskowitz Neil, Director. Officer active across 4 companies, notably Avenue Therapeutics, INC.. Cumulatively, 20 reports have been published. Breakdown: 1 buy · 2 sells. Total volume traded: €9k. Activity tracked since 6 May 2021. The latest transaction was disclosed on 30 December 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Herskowitz Neil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2,500 shares@ US$3.9999.5% of flowCommon StockSEC:0001104659-21-062774:0
Canonical exit: 4 Aug 2021 (T+90)
20 of 20 declarations
About Herskowitz Neil
Herskowitz Neil is Administrateur and a director of Journey Medical Corp, Checkpoint Therapeutics, Inc., Mustang Bio, INC. and Avenue Therapeutics, INC. Across 20 filings in total, the 20 sampled filings run from 2021-05-07 to 2026-06-26, with EUR 8265 of buys and EUR 245 of sells, and the most frequent transaction nature is Attribution.